These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21933671)

  • 1. Proximal tubules and podocytes are toxicity targets of bucillamine in a mouse model of drug-induced kidney injury.
    Fujiwara Y; Tsuchiya H; Sakai N; Shibata K; Fujimura A; Koshimizu TA
    Eur J Pharmacol; 2011 Nov; 670(1):208-15. PubMed ID: 21933671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.
    Obayashi M; Uzu T; Harada T; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Dec; 7(4):275-8. PubMed ID: 14712356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct visualization of Smad1/5/8-mediated transcriptional activity identifies podocytes and collecting ducts as major targets of BMP signalling in healthy and diseased kidneys.
    Leeuwis JW; Nguyen TQ; Chuva de Sousa Lopes SM; van der Giezen DM; van der Ven K; Rouw PJ; Offerhaus GJ; Mummery CL; Goldschmeding R
    J Pathol; 2011 May; 224(1):121-32. PubMed ID: 21381028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.
    Kanki M; Moriguchi A; Sasaki D; Mitori H; Yamada A; Unami A; Miyamae Y
    Toxicology; 2014 Oct; 324():158-68. PubMed ID: 24863737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis.
    Meyer-Schwesinger C; Dehde S; Klug P; Becker JU; Mathey S; Arefi K; Balabanov S; Venz S; Endlich KH; Pekna M; Gessner JE; Thaiss F; Meyer TN
    J Immunol; 2011 Sep; 187(6):3218-29. PubMed ID: 21844386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maleate nephrotoxicity: mechanisms of injury and correlates with ischemic/hypoxic tubular cell death.
    Zager RA; Johnson AC; Naito M; Bomsztyk K
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F187-97. PubMed ID: 17942567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
    Sakurai N; Kuroiwa T; Ikeuchi H; Hiramatsu N; Takeuchi S; Tomioka M; Shigehara T; Maeshima A; Kaneko Y; Hiromura K; Kopp JB; Nojima Y
    Nephrol Dial Transplant; 2009 Aug; 24(8):2378-83. PubMed ID: 19188342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
    Kawano M; Nomura H; Iwainaka Y; Nakashima A; Koni I; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicogenomic multigene biomarker for predicting the future onset of proximal tubular injury in rats.
    Minowa Y; Kondo C; Uehara T; Morikawa Y; Okuno Y; Nakatsu N; Ono A; Maruyama T; Kato I; Yamate J; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2012 Jul; 297(1-3):47-56. PubMed ID: 22503706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mindin: a novel marker for podocyte injury in diabetic nephropathy.
    Murakoshi M; Tanimoto M; Gohda T; Hagiwara S; Takagi M; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2011 Jul; 26(7):2153-60. PubMed ID: 21098016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclooxygenase-2 predisposes to podocyte injury.
    Cheng H; Wang S; Jo YI; Hao CM; Zhang M; Fan X; Kennedy C; Breyer MD; Moeckel GW; Harris RC
    J Am Soc Nephrol; 2007 Feb; 18(2):551-9. PubMed ID: 17202413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat.
    Williams RE; Lock EA
    Toxicology; 2005 Feb; 207(1):35-48. PubMed ID: 15590120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of naked plasmid encoding HGF attenuates puromycin aminonucleoside-induced damage of murine glomerular podocytes.
    Bu X; Zhou Y; Zhang H; Qiu W; Chen L; Cao H; Fang L; Wen P; Tan R; Yang J
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F784-92. PubMed ID: 21775482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological evaluation and treatment of bucillamine induced membranous nephropathy].
    Kikuchi M; Saeki T; Ito S; In H; Saito T; Ueno M; Sato T; Suzuki S; Nakano M; Ozawa T
    Ryumachi; 1993 Jun; 33(3):215-22. PubMed ID: 8346463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression analysis and urinary biomarker assays reveal activation of tubulointerstitial injury pathways in a rodent model of chronic proteinuria (Doxorubicin nephropathy).
    Cianciolo R; Yoon L; Krull D; Stokes A; Rodriguez A; Jordan H; Cooper D; Falls JG; Cullen J; Kimbrough C; Berridge B
    Nephron Exp Nephrol; 2013; 124(1-2):1-10. PubMed ID: 24248038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Membranous glomerulonephritis probably related to bucillamine therapy in two patients with rheumatoid arthritis].
    Baba N; Nomura T; Sakemi T; Uchida M; Watanabe T
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):629-34. PubMed ID: 1920943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity.
    Hoffmann D; Fuchs TC; Henzler T; Matheis KA; Herget T; Dekant W; Hewitt P; Mally A
    Toxicology; 2010 Nov; 277(1-3):49-58. PubMed ID: 20816719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.